CGAAY yields 74.32% · JNJ yields 2.13%● Live data
📍 CGAAY pulled ahead of the other in Year 1
Combined, CGAAY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CGAAY + JNJ for your $10,000?
A2B Australia Limited, together with its subsidiaries, provides technologies, payment, and taxi related services in Australia. The company operates through three segments: Mobility Services, Mobility Platforms, and Payments. Its mobility Services segment offers taxi networks services to taxi operators and drivers, taxi booking services, vehicle financing and insurance, and full taxi fit-outs and repairs, as well as driver training and education. The Mobility Platforms segment provides booking, payment, and dispatch technologies to mobility providers. Its Payments segment offers merchant acquiring, consulting, licensing, and other payment services. The company also provides courier services, hardware and car sales; school bus route services; and taxi equipment and rental services. The company sells its taxi network services under CAB CHARGE, Maxi Taxi and Yellow Couriers, Silver Service, 13cabs, MTI, Spotto, EFT solutions, and GIRAFFE PAYMENTS brands. A2B Australia Limited was founded in 1976 and is headquartered in Alexandria, Australia.
Full CGAAY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.